Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness

BACKGROUND: Long-acting injectable (LAI) formulations are not widely used in routine practice even though they offer advantages in terms of relapse prevention. As part of a process to improve the quality of care, the French Association for Biological Psychiatry and Neuropsychopharmacology (AFPBN) el...

Descripción completa

Detalles Bibliográficos
Autores principales: Llorca, Pierre Michel, Abbar, Mocrane, Courtet, Philippe, Guillaume, Sebastien, Lancrenon, Sylvie, Samalin, Ludovic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898013/
https://www.ncbi.nlm.nih.gov/pubmed/24359031
http://dx.doi.org/10.1186/1471-244X-13-340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898013/
https://www.ncbi.nlm.nih.gov/pubmed/24359031
http://dx.doi.org/10.1186/1471-244X-13-340

Ejemplares similares